Actinium Pharmaceuticals, Inc. (ATNM)
Operating Cash Flow Growth
3.95%
Quarterly · Period ending:
ATNM Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported3.95%period ending
Latest reported3.95%period ending
ATNM Quarterly Cash from Operations YoY % (53.61% → 3.95%)
Year-over-year change
High-resolution chart · PNG
ATNM operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 3.9503% | |
| 22.498% | |
| 8.0334% | |
| 47.1816% | |
| 32.3633% | |
| -2.7122% | |
| 23.2176% | |
| -7.6404% | |
| 41.5671% | |
| 51.0911% | |
| 3.7028% | |
| -94.6632% | |
| -148.8681% | |
| -160.8026% | |
| -53.9588% | |
| -2.2727% | |
| 709.0314% | |
| -2.4637% | |
| 19.2713% | |
| -11.8943% | |
| -1.6183% | |
| 3.6215% | |
| -24.8992% | |
| 10.7978% | |
| 15.8848% | |
| -6.6378% | |
| -16.8784% | |
| 15.3536% | |
| -27.3566% | |
| -0.5562% | |
| -35.2959% | |
| -12.6748% | |
| 41.0226% | |
| -1.5686% | |
| 25.2858% | |
| -5.3836% | |
| -14.7564% | |
| -13.0026% | |
| -6.9773% | |
| -59.1801% | |
| -18.1233% | |
| 18.176% | |
| 21.4588% | |
| 17.4569% | |
| -104.8596% | |
| -133.367% | |
| -275.4234% | |
| -161.662% | |
| -153.1925% | |
| -7.7242% | |
| 74.1347% | |
| -93,012.0115% | |
| -14,214.6603% | |
| -38,400.4662% | |
| -117,605.3895% | |
| 50.4838% | |
| -178.1708% | |
| -45.7767% | |
| 12.9852% | |
| 73.3404% | |
| -71.2042% | |
| 24.0413% | |
| -61.2135% | |
| -152.0268% | |
| 20,432.2581% | |
| 47.0829% | |
| -4.1005% | |
| -7.7462% | |
| 94.8743% | |
| -234.7485% | |
| 32.7851% | |
| -4.3198% | |
| -6.4789% | |
| 12.5143% | |
| -12.3626% | |
| 53.6092% |